Recent Progress of Deep Learning in Drug Discovery

Curr Pharm Des. 2021;27(17):2088-2096. doi: 10.2174/1381612827666210129123231.

Abstract

Deep learning, an emerging field of artificial intelligence based on neural networks in machine learning, has been applied in various fields and is highly valued. Herein, we mainly review several mainstream architectures in deep learning, including deep neural networks, convolutional neural networks and recurrent neural networks in the field of drug discovery. The applications of these architectures in molecular de novo design, property prediction, biomedical imaging and synthetic planning have also been explored. Apart from that, we further discuss the future direction of the deep learning approaches and the main challenges we need to address.

Keywords: Artificial intelligence; biomedical imaging; de novo design; deep learning; drug discovery; neural networks; property prediction; synthetic planning..

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artificial Intelligence*
  • Deep Learning*
  • Drug Discovery
  • Humans
  • Machine Learning
  • Neural Networks, Computer